Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02384018 · ClinicalTrials.gov registry record · Phase 1
Mesenchymal Stem Cell and Islet Co-transplantation
A Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT02384018: Completed Phase 1 study, sponsored by Medical University of South Carolina.
NCT02384018 is a Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 3 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02384018, a Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to show safety and tolerability to our mesenchymal stromal cells (MSCs) product which will be autologous in nature, expanded using a non-xenogeneic, human component expansion media (pooled human platelet lysate) and delivered fresh. Subsequently, the investigators intend to test whether infusion of MSCs immediately after islet autograft can reduce onset of diabetes and improve glycemic control after total pancreatectomy and islet autotransplantation.
Interventions
- BIOLOGICAL autologous mesenchymal stromal cell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-12 |
| Est. Completion | 2017-11-21 |
| Phase | Phase 1 |
What the finished NCT02384018 record still lists
NCT02384018 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which autologous mesenchymal stromal cell is the first listed.
NCT02384018 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02384018 about?
NCT02384018 is a clinical study titled "Mesenchymal Stem Cell and Islet Co-transplantation". The purpose of this study is to show safety and tolerability to our mesenchymal stromal cells (MSCs) product which will be autologous in nature, expanded using a non-xenogeneic, human component expansion media (pooled human platelet lysate) and delivered fresh. Subsequently, the investigators intend...
What is the current status of trial NCT02384018?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2014-12. Estimated completion is 2017-11-21.
What interventions are being tested in trial NCT02384018?
The interventions under investigation include: autologous mesenchymal stromal cell (BIOLOGICAL).
Who is sponsoring clinical trial NCT02384018?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02384018's enrollment target sits among peer trials
3 1999th of 2000 higher than 1 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia